Age Susceptibility of Wistar Rats to Alloxan-Induced Diabetes: A Paradox

  • Patrick E. ABA University of Nigeria, Department of Veterinary Physiology and Pharmacology, Nsukka, Enugu state
  • Miracle N. EDEH University of Nigeria, Department of Veterinary Physiology and Pharmacology, Nsukka, Enugu state
Keywords: animals; diabetogens; hyperglycemia; influence; length of time


Selection of appropriate ages of rats for experimental diabetes mellitus studies has been posing great challenges to researchers as the rats may either not come down with diabetes or may even die upon induction. This study investigated the influence of age as a possible factor affecting successful induction of diabetes mellitus in albino Wistar rats. One hundred male albino Wistar rats of varying ages weighing between 23.63 ± 0.46 g and 279.00 ± 27.00 g and assigned into ten (10) groups of ten rats per group were used for the study. Diabetes was induced in groups 1-9 consisting of rats aged 3, 5, 7, 9, 11, 13, 15, 17 and 19 weeks respectively by injecting 160 mg/kg of alloxan monohydrate intraperitoneally while group 10 rats (aged 12 weeks) served as normal control. Fasting blood glucose levels and the weights of the rats were determined on 0 h, 24 h, 48 h, 72 h and 96 h post alloxan monohydrate injection. Body conditions and behaviors of the rats were subjectively scored. Results showed that rats in groups 3-9 came down with hyperglycemia 48 h post-alloxan injection. The body conditions and behaviors of groups 3 (aged 7 weeks) and 4 (Aged 9 weeks) rats compared very well (p<0.05) with those of the normal control rats. It was concluded that rats aged 7-9 weeks were most suitable for use in studies involving induction of experimental diabetes mellitus using alloxan monohydrate at the dose of 160 mg/kg intraperitoneally.


Metrics Loading ...


Cooke DW, Plotnick L (2008). Type 1 diabetes mellitus in pediatrics. Pediatric in Review 29(11):374-84.

Dewanjee S, Bose SK, Sahu R, Mandal SC (2008). Antidiabetic effect of matured fruits of Diospyros peregrine in alloxan induced diabetic rats. International Journal of Green Pharmacy 2(2):95-99.

Erhirhie EO, Ekene NE, Ajaghaku DL (2014). Guidelines on dosage calculation and stock solution preparation in experimental animals’ studies. Journal of Natural Science Research 4(18):100-106.

Etuk EU (2010). Animal models for studying diabetes mellitus. Asian Journal of Experimental Biological Science 1(2):331-336.

Federiuk IF, Casey HM, Quinn MJ, Wood MD, Ward WK (2004). Induction of type 1 diabetes mellitus in laboratory rats by use of alloxan; route of administration, pitfalls, and insulin treatment. Comprehensive Medicine 54(3):252-257.

Haghdoost IS, Ghaleshahi AJ, Safi S (2007). Clinicopathological findings of diabetes mellitus by alloxan in goats. Comparative Clinical Pathology 16(1):53-59.

Hickman DL, Swan M (2010). Use of a body condition score technique to assess health status in a rat model of polycystic kidney disease. Journal of American Association of Laboratory Animal Science 49(2):155-159.

King AJ (2012). The use of animal models in diabetes research. British Journal of Pharmacology 166(3):877-894.

Kliber A, Szkudelski T, Chichlowska J (1996). Alloxan stimulation and subsequent inhibition of insulin release from in situ perfused rat pancreas. Journal of Physiology and Pharmacology 47(2):321-328.

Krinke GJ (2000). History, strains, and models. In: Bullock G, Bunton T (Series Ed). The Laboratory Rat (Handbook of Experimental Animals). Academic Press.

Lachin T, Reza H (2012). Antidiabetic effects of cherries in alloxan-induced diabetic rats. Recent Patents on Endocrine Metabolic and Immune Drug Discovery 6(1):67-72.

Lee JH, Yang SH, Oh JM, Lee MG (2010). Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus. Journal of Pharmacy and Pharmacology 62(1):1-23.

Lenzen S (2008). The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51(2): 216-226.

Lenzen S, Tiedge M, Jorns A, Munday R (1996). Alloxan derivatives as a tool for the elucidation of the mechanism of the diabetogenic action of alloxan. In: Shafrir E. Lessons from Animal Diabetes pp 113-122.

Rohilla A, Ali S (2012). Alloxan induced diabetes: Mechanism and effects. International Journal of Research in Pharmaceutical and Biomedical Science 3(2):819-823.

Srinivasan K, Ramarao P (2007). Animal models in type 2 diabetes research: an overview. Indian Journal of Medical Research 125(3):451-472.

Szkudelski T, Kandulska K, Okulicz M (1998). Alloxan in vivo does not only exert deleterious effects on pancreatic B cells. Physiological Research 47(5):343-346.

Tasaka Y, Inoue Y, Matsumoto H, Hirata Y (1988). Changes in plasma glucagon, pancreatic polypeptide and insulin during development of alloxan diabetes mellitus in dog. Endocrinology 35(3):399-404.

Venogopal PM, Prince PSM., Pari L (1998). Hypoglycemic activities of Syzigiumcumini seeds effect on lipid peroxidation in alloxan diabetic rats. Journal of Ethnopharmacology 61(1):1-7.

WHO (1999). Definition, diagnosis and classification of Diabetesmellitus and its complications: A Report of WHO consultation Department of Non-communicable disease surveillance Geneva, Switzerland.

How to Cite
ABA, P. E., & EDEH, M. N. (2019). Age Susceptibility of Wistar Rats to Alloxan-Induced Diabetes: A Paradox. Notulae Scientia Biologicae, 11(2), 191-195.
Research articles